Ltr Pharma Fpo has released a press release.
Recruitment commences for SPONTAN Clinical Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
Later from LTR Pharma
- First patients dosed in SPONTAN pivotal study
- Final Patients dosed in SPONTAN pivotal study
- Response to ASX Price Query
- Suspension from Quotation
- Reinstatement to quotation
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma